PATENT CLAIM ANALYSIS

Application Number: 15922921
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "135100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 2):
The antibody or antigen binding fragment according to  claim 1 , wherein the antigen-binding fragment which binds to CD122 comprises a light chain variable region sequence and a heavy chain variable region sequence, wherein:\n the light chain variable region sequence has at least 70% sequence identity to the light chain variable region sequence of SEQ ID NO:1, and the heavy chain variable region sequence has at least 70% sequence identity to the heavy chain variable region sequence of SEQ ID NO:35.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15229336', '15750425', '15908218', '15521514', '15521685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8494960651604052
- 35 USC 102 Novelty (BERT): 0.7669208019438127
- Combined Prediction Score: 0.841238538838746
- Mean Citation Score: 795.537426
- Max Citation Score: 1009.92474
- Similarity Product: 887.6448170290233

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test